Results 61 to 70 of about 158,858 (186)
New antibody‐based sandwich assays to measure plasma extracellular vesicle (EV) subsets derived from tumor tissues were developed. These EVs can be easily measured repeatedly at appropriate times. They may be useful as liquid biopsies for early cancer detection and for predicting efficacy following surgery and anti‐PD‐1 antibody in NSCLC patients ...
Tomonari Kinoshita +12 more
wiley +1 more source
Background Immune-modulatory treatments have so far shown limited clinical activity in primary brain tumours. We aimed to investigate soluble programmed death receptor ligand 1 (sPD-L1) as systemic inflammation parameter in patients with brain tumour ...
Maximilian J Mair +7 more
doaj +1 more source
This review explores liquid biopsy as a complementary approach to tissue‐based PD‐L1 assessment in advanced NSCLC treated with immune checkpoint inhibitors. Focusing on circulating tumour cells, extracellular vesicles, and circulating tumour DNA, it summarises current evidence, technical challenges, and future perspectives for personalised ...
R. Leporati +15 more
wiley +1 more source
Gadusol‐rich extracts provide effective UVB protection and antioxidant activity in HaCaT cells and C. elegans, highlighting their potential as natural photochemoprotective agents for pharmaceutical and cosmetic applications. It also demonstrates remarkable in vitro antioxidant capacity and thermal stability over time.
Rocío Isla Naveira +9 more
wiley +1 more source
A high expression level of programmed death-ligand 1 (PD-L1) is observed in different types of cancers (particularly lung cancer). Soluble (s)PD-L1 may be used as a prognostic marker and a target for anti-cancer immunity, as well as, predicting gene ...
Ali Razaghi +5 more
doaj +1 more source
Introduction: Response to platinum-based therapy is a major prognostic factor in epithelial ovarian cancer (EOC) and reliable prognostic biomarkers are urgently needed to identify patients at high risk.
Vera Rebmann (477041) +6 more
core +1 more source
The clinical significance of plasma soluble programmed cell death ligand 1 (sPD-L1) and vascular endothelial growth factor (VEGF) for non-small cell lung cancer (NSCLC) treated with the combination of anti-angiogenic therapy and anti-PD-L1 antibody (Ab) remain unknown.
Changhong, Dong +5 more
openaire +2 more sources
Cell division promotes efficient retrotransposition in a stable L1 reporter cell line [PDF]
Background: Long interspersed element type one (L1) actively modifies the human genome by inserting new copies of itself. This process, termed retrotransposition, requires the formation of an L1 ribonucleoprotein (RNP) complex, which must enter the ...
Ivics, Z. +17 more
core +1 more source
BackgroundInhibition of the programmed cell death-1/programmed cell death-ligand 1 (PD-1/PD-L1) axis in combination with radiotherapy may be a promising approach to treat cancer.
Tetsuro Tominaga +7 more
doaj +1 more source
ABSTRACT Vaginal self‐sampling is increasingly integrated into cervical cancer screening programs, requiring evidence of accurate HPV testing on self‐collected samples. This study evaluated the clinical accuracy of Allplex HPV HR Detection (Allplex) within VALHUDES, a framework established to assess the clinical performance of HPV assays on self ...
Ardashel Latsuzbaia +9 more
wiley +1 more source

